126
|
Rosenberg RN. At jeopardy: the NIH as we know it. J Neurol Sci 2003; 214:1-2. [PMID: 12972379 DOI: 10.1016/s0022-510x(03)00222-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
127
|
Rosenberg RN, Pedley TA, Baringer JR, Fahn S, Lisak RP, Mayeux RP, Olson SF, Ringel SP, Rowland LP, Selzer ME. At jeopardy: the NIH as we know it. ARCHIVES OF NEUROLOGY 2003; 60:1191-2. [PMID: 12975281 DOI: 10.1001/archneur.60.9.1191] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
128
|
Baskin F, Rosenberg RN, Fang X, Hynan LS, Moore CB, Weiner M, Vega GL. Correlation of statin-increased platelet APP ratios and reduced blood lipids in AD patients. Neurology 2003; 60:2006-7. [PMID: 12821755 DOI: 10.1212/01.wnl.0000068029.56740.96] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
Abstract
Platelets, like neurons, contain 120- to 130- and 110-kd amyloid precursor proteins (APPs). Their ratio is reduced in AD, further reductions correlating with reduced Mini-Mental Status Examination scores [r(11) = 0.69, p < 0.05]. As statins alter APP processing, platelet APPs were analyzed in patients with AD given anticholesterol drugs for 6 weeks. APP ratios increased [t(37) = -3.888, p = 0.0004], proportionally with reduced cholesterol [r(36) = -0.45, p = 0.005]. Longer trials may reveal slowed cognitive loss, validating this index.
Collapse
|
129
|
|
130
|
Weiner MF, Rosenberg RN, Cullum M. Comment on "American Indians/Alaska natives and dementia". Alzheimer Dis Assoc Disord 2003; 17:132; author reply 132. [PMID: 12794393 DOI: 10.1097/00002093-200304000-00014] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
131
|
|
132
|
|
133
|
|
134
|
|
135
|
Rosenberg RN. Explaining the cause of the amyloid burden in Alzheimer disease. ARCHIVES OF NEUROLOGY 2002; 59:1367-8. [PMID: 12223021 DOI: 10.1001/archneur.59.9.1367] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
136
|
Rosenberg RN. The molecular genetics of neurological disease. INTERNATIONAL JOURNAL OF NEUROLOGY 2002; 25-26:20-8. [PMID: 11980060] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 04/18/2023]
|
137
|
Rosenberg RN, Aminoff M, Boller F, Soerensen PS, Griggs RC, Hallett M, Johnson RT, Kennard C, Lang AE, Lees AJ, Lisak R, Newsom-Davis J, Pedley TA, Selzer ME, Zochodne D. Reporting clinical trials: full access to all the data. Neurorehabil Neural Repair 2002; 15:157-8. [PMID: 11944735] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/24/2023]
|
138
|
Rosenberg RN, Aminoff M, Boller F, Soerensen PS, Griggs RC, Hachinski V, Hallett M, Johnson RT, Kennard C, Lang AE, Lees AJ, Lisak R, Newsom-Davis J, Pedley TA, Selzer ME, Zochodne D. Reporting clinical trials: full access to all the data. Author's right to access to all data obtained in their study. J Neurol 2002; 249:638-9. [PMID: 12021961 DOI: 10.1007/s004150200080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
139
|
Rosenberg RN, Aminoff M, Boller F, Soerensen PS, Griggs RC, Hachinski V, Hallett M, Johnson RT, Kennard C, Lang AE, Lees AJ, Lisak R, Newsom-Davis J, Pedley TA, Selzer ME, Zochodne D. Reporting clinical trials: full access to all the data. Brain 2002; 125:i-ii. [PMID: 11872625 DOI: 10.1093/brain/awf120] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
|
140
|
Lacritz LH, Cullum CM, Weiner MF, Rosenberg RN. Comparison of the hopkins verbal learning test-revised to the California verbal learning test in Alzheimer's disease. APPLIED NEUROPSYCHOLOGY 2002; 8:180-4. [PMID: 11686654 DOI: 10.1207/s15324826an0803_8] [Citation(s) in RCA: 55] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 10/31/2022]
Abstract
We examined the validity of the revised Hopkins Verbal Learning Test (HVLT-R) by comparing performances on the HVLT-R and the California Verbal Learning Test (CVLT) in participants with Alzheimer's disease (AD). Total learning, delayed recall, intrusion errors, and recognition performance were significantly related across tests, but the number of perseverative responses showed no linear association. Despite similar results across measures, some of the variables were only modestly correlated, which may reflect differences in test procedures and the limited range of scores for some variables. Furthermore, the HVLT-R may not be challenging enough to elicit some of the types of recall errors commonly seen in AD to the same extent as the CVLT Nonetheless, the HVLT-R shows promise for providing a multidimensional assessment of verbal learning and memory and may be ideal in cases where brief assessment ofmemory and/or serial evaluations are needed.
Collapse
|
141
|
Rosenberg RN, Aminoff M, Boller F, Sørenson PS, Griggs RC, Hachinski V, Hallett M, Johnson RT, Kennard C, Lang AE, Lees AJ, Lisak R, Newsom-Davis J, Pedley TA, Selzer ME, Zochodne D. Reporting clinical trials: full access to all the data. Neurology 2002; 58:347-8. [PMID: 11839830 DOI: 10.1212/wnl.58.3.347] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022] Open
|
142
|
Rosenberg RN, Aminoff MJ, Boller F, Soerensen PS, Griggs RC, Hachinski V, Hallett M, Johnson RT, Kennard C, Lang AE, Lees AJ, Lisak R, Newsom-Davis J, Pedley TA, Selzer ME, Zochodne D. Reporting clinical trials: full access to all the data. Muscle Nerve 2002; 25:133-4. [PMID: 11870680 DOI: 10.1002/mus.1229] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
143
|
Rosenberg RN, Aminoff M, BoIler F, Soerensen PS, Griggs RC, Hachinski V, Hallett M, Johnson RT, Kennard C, Lang AE, Lees AJ, Lisak R, Newsom-Davis J, Pedley TA, SeIzer ME, Zochodne D. Reporting clinical trials: full access to all the data. J Neurol Neurosurg Psychiatry 2002; 72:143. [PMID: 11796759 PMCID: PMC1737720 DOI: 10.1136/jnnp.72.2.143] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Authors' right to access to all data obtained in their study
Collapse
|
144
|
Rosenberg RN, Aminoff M, Boller F, Soerensen PS, Griggs RC, Hachinski V, Hallett M, Johnson RT, Kennard C, Lang AE, Lees AJ, Lisak R, Newsom-Davis J, Pedley TA, Selzer ME, Zochodne D. Reporting clinical trials: full access to all of the data. ARCHIVES OF NEUROLOGY 2002; 59:27-8. [PMID: 11790226 DOI: 10.1001/archneur.59.1.27] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
145
|
Rosenberg RN, Aminoff M, Boller F, Soerensen PS, Griggs RC, Hallett M, Hachinski V, Johnson RT, Kennard C, Lang AE, Lees AJ, Lisak R, Newsom-Davis J, Pedley TA, Selzer ME, Zochodne D. Reporting clinical trials: full access to all the data. Mov Disord 2002; 17:3-4. [PMID: 11835431 DOI: 10.1002/mds.10102] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022] Open
|
146
|
Rosenberg RN. Genomics and the transformation of neurology. JAMA 2001; 286:2869-70. [PMID: 11767734 DOI: 10.1001/jama.286.22.2869] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/14/2022]
|
147
|
Rosenberg RN, Aminoff M, Boller F, Soelberg P, Griggs RC, Hachinski V, Hallett M, Johnson RT, Kennard C, Lang AE, Lees AJ, Lisak R, Newsom-Davis J, Pedley TA, Selzer ME, Zochodne D. Reporting clinical trials: full access to all the data. Stroke 2001; 32:2734. [PMID: 11739964] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/22/2023]
|
148
|
|
149
|
|
150
|
Cooper DB, Epker M, Lacritz L, Weine M, Rosenberg RN, Honig L, Cullum CM. Effects of practice on category fluency in Alzheimer's disease. Clin Neuropsychol 2001; 15:125-8. [PMID: 11778573 DOI: 10.1076/clin.15.1.125.1914] [Citation(s) in RCA: 51] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Evaluation of patients with suspected Alzheimer's disease (AD) often involves clinicians of multiple disciplines working in collaboration to maximize diagnostic accuracy. Accordingly, repeated administrations of some common tests of mental status may occur within a relatively brief time period. The effect of such retesting on subsequent results is largely unknown for many cognitive tasks, despite the possibility that repeated administrations may artificially inflate scores. To assess the potential impact of practice effects on a commonly administered verbal fluency task, animal naming was administered twice within a 1-week period to 111 patients with probable AD and 12 persons without dementia. Non-demended subjects were the only group to demonstrate a small (3 point), but statistically significant practice effect. Regardless of level of cognitive impairment, patients with AD did not show significant practice effects over repeated administrations of animal naming after a relatively brief test-retest interval, suggesting the robust nature of this task in AD.
Collapse
|